Home
Dashboard
Info
Curated content
Blue Economy Guide
Blue Companies
Oceans and Sea Basins
Blue Finance
Blue Igniters
AspBAN
Investment heatmap
Matching tool
Companies
Arxx Therapeutics
Team
Team
Save
Arxx Therapeutics
Develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis.
Launch date
2019
Employees
2-10 people
Company register number
815295242
Oslo Norway (HQ)
View more
https://arxxtx.com/
https://www.linkedin.com/company/arxx-therapeutics/
B2B
manufacturing
commission
health
biotechnology
hard tech
biotechnology
Overview
Similar companies
Investments (1)
Analytics
Notes
Job openings
Innovations (0)
Patents (2)
Authorizing premium user...